"Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors." Vascular Health and Risk Management, 2(2), pp. 95–96
Open access
50
Views
1
CrossRef citations to date
0
Altmetric
Editorial Foreword
Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
Reza TabrizchiDivision of Basic Medical Sciences, Faculty of Medicine, Memorial University of NewfoundlandSt John's, NL, Canada
Pages 95-96
|
Published online: 24 Dec 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.